(Updated - July 16, 2026 9:10 AM EDT)

Canaccord analyst John Newman initiates coverage on Relay Therapeutics (NASDAQ: RLAY) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE